NCT00526656 Sunitinib in Treating Patients With Locally Advanced Bladder Cancer Status COMPLETED Phase PHASE2
NCT00516750 Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Status TERMINATED Phase PHASE2
NCT00506155 Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer Status COMPLETED Phase PHASE2
NCT00491296 Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia Status UNKNOWN Phase N/A
NCT00490880 Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer Status COMPLETED Phase PHASE2
NCT00479089 Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer Status TERMINATED Phase PHASE2
NCT00471432 OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors Status COMPLETED Phase PHASE1
NCT00465725 A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00462488 Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ Status COMPLETED Phase PHASE2
NCT00461851 Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma Status COMPLETED Phase PHASE2
NCT00461591 Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) Status COMPLETED Phase PHASE3
NCT00445601 S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Status COMPLETED Phase PHASE3
NCT00421889 A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment Status COMPLETED Phase PHASE1/PHASE2
NCT00412971 A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer Status COMPLETED Phase PHASE3
NCT00397488 Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium Status COMPLETED Phase PHASE2
NCT00393796 Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma Status TERMINATED Phase PHASE2
NCT00389155 First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy Status COMPLETED Phase PHASE2/PHASE3
NCT00380029 Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer Status COMPLETED Phase PHASE2
NCT00365508 Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking Status COMPLETED Phase PHASE4